Cell Bank of Epstein Barr Virus Specific Cytotoxic T Lymphocytes

Inclusion Criteria: * Male or female, without immunosuppressed organ transplant or immunocompromised and who received a kidney transplant, or kidney-pancreas, or heart or lung or heart-lung, or liver, or cells hematopoietic stem cells, and has given its consent * Aged 18 to 75 years Children aged more than 12 months, * PS \<4 * Viral load determined EBV * Life expectancy\> 1 month * Patient typed for HLA DP DQ DR ABC * Patients with lymphoma in the immunosuppressed associated with EBV and failure, partial response (\<50%) or relapsed after treatment with monoclonal antibodies and / or chemotherapy completed for at least three weeks. Patients with partial response may have a PET scan to confirm the lack of response. * Patient with a measurable mass to assess the response or bone marrow infiltration and / or measurable blood and having frozen tumor material or having a repeat biopsy. * Availability of a CTL matching at least two HLA or one HLA after validation experts with tumor cells * test de cytotoxicity negative Exclusion Criteria: * Patient Pregnant or lactating * Concurrent infection with HIV * EBV negative lymphomas * If acute GVHD\> grade II J-1 before injection (case grafts CSH) * Treatment of molecules in pre-marketing authorization older than 21 days * No matching at least two CTL HLA or non expert validation for the use of CTL with HLA sharing a single tumor * Test of cytotoxicity positive * Lack of recognition of tumor cells when available